__NUXT_JSONP__("/drugs/Ovapuldencel-T", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A cancer vaccine consisting of autologous dendritic cells (DCs) loaded with autologous, lethally irradiated cancer cells and mixed with the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulatory and antineoplastic activities. Upon vaccination, ovapuldencel-T may stimulate the immune system to exert a cytotoxic T-lymphocyte (CTL) immune response against the repertoire of tumor associated antigens (TAAs) found in the irradiated cancer cells. GM-CSF enhances the activation of dendritic cells (DCs) and promotes antigen presentation to both B- and T-lymphocytes.",fdaUniiCode:"FK2WI4Y35P",identifier:"C113651",preferredName:a,semanticType:"Cell",subclassOf:["C2594"],synonyms:["OVAPULDENCEL-T",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FOvapuldencel-T",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Ovapuldencel-T","","2021-10-30T13:18:37.823Z")));